MediPress Health-Limited Partnership (TLV:MPRS)
Israel · Delayed Price · Currency is ILS · Price in ILA 52.80
+5.00 (10.46%)
At close: Aug 19, 2025
MediPress Health-Limited Partnership Company Description
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments.
The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders.
The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.
MediPress Health-Limited Partnership
| Country | Israel |
| Founded | 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Joseph Press |
Contact Details
Address: 40 Tuval Street Ramat Gan, 5252247 Israel | |
| Phone | 972 50 4057333 |
Stock Details
| Ticker Symbol | MPRS |
| Exchange | Tel Aviv Stock Exchange |
| Reporting Currency | ILS |
| ISIN Number | IL0011828980 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Prof. Joseph Press M.D. | Chairman and Chief Executive Officer |